Caroline Vu

Cooley advised Kite Pharma, a Gilead company, dedicated to developing active immunotherapies, in the formation of a clinical collaboration with Humanigen, Inc. to conduct a Phase ½ study of lenzilumab, an investigational anti-GM-CSF monoclonal antibody, with Yescarta® (axicabtagene ciloleucel) in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). The goal of this collaboration is to determine the effect of lenzilumab on the clinical profile of Yescarta. Financial terms were not disclosed. Cooley special counsel Caroline Vu advised Kite.

Cooley advised Kite Pharma, a Gilead company, dedicated to developing active immunotherapies, in its clinical collaboration with Kiniksa Pharmaceuticals to conduct a Phase 2, multicenter study of mavrilimumab, an investigational fully human monoclonal antibody that targets granulocyte macrophage colony stimulating factor receptor alpha (GM-CSFRα), in combination with Yescarta® (axicabtagene ciloleucel) in patients with relapsed or refractory large B-cell lymphoma. The goal of this collaboration is to determine the effect of mavrilimumab on the clinical profile of Yescarta. Financial terms were not disclosed. Cooley special counsel Caroline Vu advised Kite.

Cooley advised DFJ Growth on its growth investment in Paradigm Health, a company on a mission to bring equitable access to clinical trials. This investment will bolster Paradigm’s innovative efforts and accelerate its growth trajectory. DFJ Growth is a venture capital firm that focuses on investing in innovative, high-growth companies. Lawyer Sale Kwon led the Cooley team advising DFJ Growth.

Cooley advised Jiangsu Hengrui Pharmaceuticals (Hengrui Pharma), a global pharmaceutical company focused on scientific and technological innovation, on its exclusive license agreement with Merck KGaA, Darmstadt, Germany for the commercialization in mainland China of SHR7280, an oral small-molecule gonadotropin-releasing hormone receptor antagonist, for indications including medical-assisted reproduction and gynecology.